	Risedronate
Fragility fracture
Vertebral fracture
Bisphosphonates
Nonvertebral fracture
Osteopenia
	femoral neck Tscore
fracture risk
prevalent vertebral fractures
fragility fractures
low bone mass
femoral neck
postmenopausal women
risedronate
osteopenic
osteoporosis
risk
Tscores
women
trials
analysis
patients
adverse events
treatment
population
limited data
study
trabecular architecture
data
similar
effect
fractures
risk reduction
bone microarchitecture
years
clinical vertebral
placebo
significant reductions
BMD
due
nonvertebral

